Silexion Therapeutics Corp increased its authorized share capital by 10 million ordinary shares to $2,146,500, allowing for the issuance of additional equity. Market relevance remains neutral until specific use of funds is disclosed.
Silexion Therapeutics Corp increased its authorized share capital by 10 million ordinary shares to $2,146,500, allowing for the issuance of additional equity. Market relevance remains neutral until specific use of funds is disclosed.